OSL · MEDI.OL
Medistim ASA
NOK 307.00NOK 0.00 (0.0%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
Loading market information…
OSL · ABT.OL · NOK
Stock price, dividends, earnings
Quote as of Feb 27, 2023, 03:25 PM UTC. Cached market data; not a live quote.
Price history is currently unavailable.
Aqua Bio Technology ASA’s quoted price sits in the lower half of its reported 52-week range, 45.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Aqua Bio Technology ASA’s forward annual dividend is NOK 1.99 per share, paid semi-annual. The forward yield is 28.75% at the quoted price. Future payments can change.
Dividend payment history is currently unavailable.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Aqua Bio Technology ASA’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Aqua Bio Technology ASA (ABT) is a Norwegian firm that develops and markets specialized ingredients for the cosmetics sector. Its product portfolio includes Aquabeautine XL, a unique active compound designed for skincare applications, and Spirulysat, an antioxidant-rich, vitamin-enhanced spirulina extract utilized in cosmetic formulations. The company distributes its offerings through online platforms, retail outlets, and professional skincare clinics. Established in 2000, Aqua Bio Technology ASA has its headquarters located in Lysaker, Norway.
Latest available per-share figures in NOK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NOK 307.00NOK 0.00 (0.0%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
NOK 10.44-NOK 0.10 (-0.95%)
Circio Holding ASA’s quoted price sits in the upper half of its reported 52-week range, 33.5% below the high.
NOK 25.80NOK 0.00 (0.0%)
Nordhealth AS’s quoted price sits in the lower half of its reported 52-week range, 32.81% below the high.
NOK 4.12-NOK 0.10 (-2.25%)
Thor Medical ASA’s quoted price sits in the lower half of its reported 52-week range, 42.13% below the high.
NOK 46.75+NOK 0.05 (+0.11%)
Photocure ASA’s quoted price sits in the lower half of its reported 52-week range, 41.42% below the high.
NOK 3.06+NOK 0.04 (+1.32%)
Nykode Therapeutics AS’s quoted price sits in the lower half of its reported 52-week range, 41.15% below the high.
NOK 21.10-NOK 0.30 (-1.4%)
ArcticZymes Technologies ASA’s quoted price sits in the lower half of its reported 52-week range, 27.24% below the high.
NOK 44.80-NOK 1.20 (-2.61%)
Omda AS’s quoted price sits in the upper half of its reported 52-week range, 12.84% below the high.
